Computerized analysis of heart arteries shows no benefits of hormone therapy

March 13, 2000

WINSTON-SALEM, N.C. -- In a major new study of the effects of hormone replacement therapy (HRT) on heart disease, researchers found that neither estrogen, nor estrogen combined with a progestin, slowed disease progression in 309 older women.

"This study provides additional evidence that HRT may not be as effective as we once thought in slowing heart disease," said David Herrington, M.D., M.H.S., of Wake Forest University Baptist Medical Center. "The message for women and their physicians is to make full use of proven therapies, such as cholesterol-lowering drugs, and not assume that HRT is an effective alternative for treatment of heart disease."

Herrington reported the findings today at the American College of Cardiology's annual meeting. The study, the Estrogen Replacement and Atherosclerosis (ERA) trial, used cardiac catheterization, a test that injects dye into the arteries, to measure narrowing in the heart's arteries caused by a buildup of cholesterol. As vessel disease progresses, these narrowings worsen.

A total of 309 older women with heart disease were randomly assigned to take estrogen (Premarin®), estrogen combined with a progestin (Prempro®), or a dummy pill (placebo). Sophisticated computer techniques were used to measure subtle changes in their arteries over the study period (an average of three years.)

"Overall, there were no differences between the groups in how quickly the disease progressed, " said Herrington, associate professor of cardiology. "HRT did lower cholesterol, but these changes didn't translate into a measurable benefit in the arteries of the heart."

The mean age of the women in ERA was 65.8 years. Almost half (48 percent) of the women were heart attack survivors.

The ERA study provides one more piece to the "puzzle" that scientists are working on about HRT's risks and benefits.

"Based on this study, we can't rule out a small benefit of estrogen, but a dramatic effect as seen with lipid-lowering therapy in patients with high cholesterol, is extremely unlikely," said Herrington.

ERA is the second major clinical study that calls into question the widely held belief that HRT is an effective treatment for heart disease. In 1998, HERS (the Heart and Estrogen/progestin Replacement Study) found that 2,763 women who took estrogen and a progestin for four years had just as many heart attacks as women who didn't take the treatment.

As a result, it was recommended that women with heart disease not begin HRT to lower their risk for future heart attacks and heart disease deaths.

"ERA supports the findings of HERS. In both studies, there was no clear-cut evidence of benefit in women with established heart disease," said Herrington. He pointed out that the results don't necessarily apply to younger, healthier women.

"Other studies, such as the Women's Health Initiative, are looking at the effects of HRT in younger women. These studies will further clarify what role, if any, HRT may play in the prevention of heart disease."

ERA study sites were at Wake Forest University Baptist Medical Center, Forsyth Medical Center in Winston-Salem, Moses Cone Hospital in Greensboro, Carolinas Medical Center in Charlotte, Hartford Hospital in Hartford, Conn., and the University of Alabama at Birmingham. The study was funded by the National Institutes of Health.
Media Contacts: Karen Richardson, (336) 716-4453, Mark Wright (336) 716-4587 or Jim Steele, (336) 716-3487.

Wake Forest Baptist Medical Center

Related Heart Disease Articles from Brightsurf:

Cellular pathway of genetic heart disease similar to neurodegenerative disease
Research on a genetic heart disease has uncovered a new and unexpected mechanism for heart failure.

Mechanism linking gum disease to heart disease, other inflammatory conditions discovered
The link between periodontal (gum) disease and other inflammatory conditions such as heart disease and diabetes has long been established, but the mechanism behind that association has, until now, remained a mystery.

New 'atlas' of human heart cells first step toward precision treatments for heart disease
Scientists have for the first time documented all of the different cell types and genes expressed in the healthy human heart, in research published in the journal Nature.

With a heavy heart: How men and women develop heart disease differently
A new study by researchers from McGill University has uncovered that minerals causing aortic heart valve blockage in men and women are different, a discovery that could change how heart disease is diagnosed and treated.

Heart-healthy diets are naturally low in dietary cholesterol and can help to reduce the risk of heart disease and stroke
Eating a heart-healthy dietary pattern rich in vegetables, fruits, whole grains, low-fat dairy products, poultry, fish, legumes, vegetable oils and nuts, which is also limits salt, red and processed meats, refined-carbohydrates and added sugars, is relatively low in dietary cholesterol and supports healthy levels of artery-clogging LDL cholesterol.

Pacemakers can improve heart function in patients with chemotherapy-induced heart disease
Research has shown that treating chemotherapy-induced cardiomyopathy with commercially available cardiac resynchronization therapy (CRT) delivered through a surgically implanted defibrillator or pacemaker can significantly improve patient outcomes.

Arsenic in drinking water may change heart structure raising risk of heart disease
Drinking water that is contaminated with arsenic may lead to thickening of the heart's main pumping chamber in young adults, according to a new study by researchers at Columbia University Mailman School of Public Health.

New health calculator can help predict heart disease risk, estimate heart age
A new online health calculator can help people determine their risk of heart disease, as well as their heart age, accounting for sociodemographic factors such as ethnicity, sense of belonging and education, as well as health status and lifestyle behaviors.

Wide variation in rate of death between VA hospitals for patients with heart disease, heart failure
Death rates for veterans with ischemic heart disease and chronic heart failure varied widely across the Veterans Affairs (VA) health care system from 2010 to 2014, which could suggest differences in the quality of cardiovascular health care provided by VA medical centers.

Heart failure: The Alzheimer's disease of the heart?
Similar to how protein clumps build up in the brain in people with some neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, protein clumps appear to accumulate in the diseased hearts of mice and people with heart failure, according to a team led by Johns Hopkins University researchers.

Read More: Heart Disease News and Heart Disease Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to